FolioLanternBeta
REGNRegeneron Pharmaceuticals

Daniel Van Plew

EVP & General Mgr, Industrial at Regeneron Pharmaceuticals, as of Dec 11, 2025No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1
company filed for

Shares held at Regeneron Pharmaceuticals is not shown: the holdings do not reconcile with the filings. Why

Last filing: Dec 11, 2025. Most recent sale before this period: Feb 14, 2024.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Regeneron Pharmaceuticals (REGN)EVP & General Mgr, IndustrialSep 11, 2007Dec 11, 2025

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.